Clients

MPM BioVentures IV

$550,000,000

MPM BioVentures IV

MPM BioVentures IV was formed to make private equity investments in innovative healthcare companies across all stages of their lifecycles in the U.S. and abroad with an emphasis on those companies that are product-focused and close to achieving critical, value-enhancing milestones or "value inflection points." Following a precedent set in prior funds, MPM BioVentres IV will include venture capital investments as well as more opportunistically, growth equity investments.  In February 2007, MPM BioVentures IV achieved $550 million of committed capital.

MPM Capital is one of the world's largest life science-dedicated venture investors uniquely structured to invest globally in healthcare innovation.

Back to Clients